HLA
XLRN
Hamilton Lane Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-69,503
| Closed | -$2.95M | – | 57 |
|
2017
Q4 | $2.95M | Sell |
69,503
-5,487
| -7% | -$233K | 1.52% | 19 |
|
2017
Q3 | $2.8M | Sell |
74,990
-8,000
| -10% | -$299K | 1.92% | 12 |
|
2017
Q2 | $2.52M | Sell |
82,990
-10,000
| -11% | -$304K | 1.38% | 19 |
|
2017
Q1 | $2.46M | Hold |
92,990
| – | – | 1.24% | 22 |
|
2016
Q4 | $2.37M | Buy |
92,990
+59,650
| +179% | +$1.52M | 1.56% | 19 |
|
2016
Q3 | $1.21M | Hold |
33,340
| – | – | 0.61% | 35 |
|
2016
Q2 | $1.14M | Sell |
33,340
-4,064
| -11% | -$139K | 0.55% | 34 |
|
2016
Q1 | $987K | Sell |
37,404
-4,488
| -11% | -$118K | 0.47% | 34 |
|
2015
Q4 | $2.04M | Sell |
41,892
-571
| -1% | -$27.8K | 0.9% | 24 |
|
2015
Q3 | $1.06M | Hold |
42,463
| – | – | 0.52% | 32 |
|
2015
Q2 | $1.34M | Buy |
42,463
+19,816
| +87% | +$627K | 0.51% | 35 |
|
2015
Q1 | $862K | Sell |
22,647
-19,902
| -47% | -$758K | 0.39% | 31 |
|
2014
Q4 | $1.66M | Buy |
+42,549
| New | +$1.66M | 0.63% | 28 |
|
2014
Q2 | – | Sell |
-9,805
| Closed | -$338K | – | 72 |
|
2014
Q1 | $338K | Buy |
+9,805
| New | +$338K | 0.14% | 57 |
|